We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Want Clarity in Guidance on Gauging Suicidal Thoughts, Behaviors
Sponsors Want Clarity in Guidance on Gauging Suicidal Thoughts, Behaviors
October 26, 2012
Amgen and Novartis want the FDA to clarify which compounds would require an assessment of suicidal thoughts and behaviors under draft guidance the agency issued in August.